Muthu Meiyappan
Head of Technology Development & Implementation Takeda Pharmaceutical
Muthu Meiyappan has over 20 years of experience in Protein Biochemistry and Structural Biology. He got his Ph.D degree from Indian Institute of Science in India and post-doctoral training at Cornell and Harvard Universities in USA. He joined Shire, now part of Takeda, in 2009, worked on molecular biology, protein engineering, purification and characterization of various biomolecular research and development candidates. Muthu, a two times CEO award winner at Shire, is currently heading Analytical Research group in Discovery Therapeutics department. His group is involved in molecular selection and characterization of biotherapeutic research and development candidates as well as characterization of protein targets for small molecule drug discovery.
Seminars
- Defining who owns technology, data, and decision making at each stage, from early development through tech transfer and into GMP manufacturing, to prevent gaps that stall adoption
- Addressing the practical steps required to contextualize data, integrate systems into workflows, and ensure data management tools actively support process monitoring and decision making
- Sharing lessons learned from driving organizational alignment, ownership, and accountability to ensure successful implementation and sustained use across sites and functions
